News

Filter

Current filters:

None

76 to 85 of 96949 results

Sanofi and Regeneron’s dupilumab gets Breakthrough designation from FDA

20-11-2014

The US Food and Drug Administration has granted Breakthrough Therapy designation to French pharma major…

BiotechnologyDermatologicalsdupilumabRegeneronRegulationSanofiUSA

Shire to relocate 500 employees in formation of new hub in Lexington, Massachusetts

Shire to relocate 500 employees in formation of new hub in Lexington, Massachusetts

19-11-2014

Following AbbVie’s recent abandonment of a $53 billion takeover offer, Ireland-headquartered drugmaker…

Business FinancePharmaceuticalPunctuationShireUSA

Royalty Pharma pays $3.3 billion for CFF royalty rights to Kalydeco

19-11-2014

Royalty Pharma says it has acquired royalties on Vertex Pharmaceuticals' cystic fibrosis treatments,…

BiotechnologyFinancialKalydecoRare diseasesRoyalty PharmaVertex Pharmaceuticals

Valeant admits disappointment at loss of takeover target Allergan to Actavis

Valeant admits disappointment at loss of takeover target Allergan to Actavis

19-11-2014

Canadian drugmaker Valeant International has admitted that the loss of hostile takeover target Allergan…

ActavisAllerganCanadaMergers & AcquisitionsPharmaceuticalValeant

Despite patent cliffs, pharma market shows signs of stability

19-11-2014

The pharmaceutical market is beginning to show signs of stability, with a review of 30 leading companies…

Biogen IdecBoehringer IngelheimFinancialJohnson & JohnsonPatentsPfizerPharmaceutical

UK diabetes patients being denied vital prescriptions for testing strips

19-11-2014

Patients in Britain with diabetes are missing out on vital prescriptions that let them keep tabs on their…

DiabetesHealthcarePharmaceuticalUK

Sanofi and Regeneron's alirocumab achieves positive Phase III results in reducing LDL

Sanofi and Regeneron's alirocumab achieves positive Phase III results in reducing LDL

19-11-2014

French drug major Sanofi and partner Regeneron Pharmaceuticals have reported results of six Phase III…

alirocumabBiotechnologyGastro-intestinalsRegeneron PharmaceuticalsResearchSanofi

Threat or promise by 2020? The FT Global Pharmaceutical and Biotechnology Conference 2014

Threat or promise by 2020? The FT Global Pharmaceutical and Biotechnology Conference 2014

19-11-2014

The Pharma Letter reports from the FT Global Pharmaceutical and Biotechnology Conference 2014.

FT Global PharmaceuticalMarkets & MarketingPharmaceuticalResearchUK

Cost of bringing new drug to market now around $2.6 billion, says Tufts CSDD

19-11-2014

Developing a new prescription medicine that gains marketing approval, a process often lasting longer…

FinancialGlobalPharmaceuticalResearch

76 to 85 of 96949 results

Parexel

Parexel

Back to top